BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37733980)

  • 21. A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors.
    Conley CC; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Burgos C; Ricker C; Kim J; Graves KD; Ashing KT; Quinn GP; Soliman H; Vadaparampil ST
    J Genet Couns; 2021 Apr; 30(2):394-405. PubMed ID: 32936981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
    Wang C; Gonzalez R; Milliron KJ; Strecher VJ; Merajver SD
    Am J Med Genet A; 2005 Apr; 134A(1):66-73. PubMed ID: 15690408
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Harriman JW; Espinel WF; Vagher J; Gammon A
    JCO Precis Oncol; 2022 Oct; 6():e2100375. PubMed ID: 36201716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.
    Demarco TA; Nusbaum RH; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Tercyak KP
    Patient Educ Couns; 2010 Jan; 78(1):29-33. PubMed ID: 19545972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
    Ledet EM; Burgess EF; Sokolova AO; Jaeger EB; Hatton W; Moses M; Miller P; Cotogno P; Layton J; Barata P; Lewis BE; Nakazawa M; Zhu J; Dellinger B; Elrefai S; Nafissi NN; Egan JB; Shore N; McKay RR; Bryce AH; Cheng HH; Antonarakis ES; Sartor O
    Prostate; 2021 May; 81(7):433-439. PubMed ID: 33792945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW
    JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer.
    Tutty E; Petelin L; McKinley J; Young MA; Meiser B; Rasmussen VM; Forbes Shepherd R; James PA; Forrest LE
    Eur J Hum Genet; 2019 Aug; 27(8):1186-1196. PubMed ID: 30962500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.
    Greenberg SE; Hunt TC; Ambrose JP; Lowrance WT; Dechet CB; O'Neil BB; Tward JD
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.
    Manchanda R; Burnell M; Loggenberg K; Desai R; Wardle J; Sanderson SC; Gessler S; Side L; Balogun N; Kumar A; Dorkins H; Wallis Y; Chapman C; Tomlinson I; Taylor R; Jacobs C; Legood R; Raikou M; McGuire A; Beller U; Menon U; Jacobs I
    J Med Genet; 2016 Jul; 53(7):472-80. PubMed ID: 26993268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.
    Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    BMC Womens Health; 2012 May; 12():12. PubMed ID: 22569005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
    J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
    Bednar EM; Oakley HD; Sun CC; Burke CC; Munsell MF; Westin SN; Lu KH
    Gynecol Oncol; 2017 Aug; 146(2):399-404. PubMed ID: 28610746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring patient and provider perspectives on the intersection between fertility, genetics, and family building.
    Lake PW; Kasting ML; Dean M; Fuzzell L; Hudson J; Carvajal R; Reed DR; Quinn GP; Vadaparampil ST
    Support Care Cancer; 2020 Oct; 28(10):4833-4845. PubMed ID: 31982959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing.
    Mooney R; Espinel W; Elrick A; Kehoe K; Kohlmann W; Kaphingst KA
    J Genet Couns; 2022 Apr; 31(2):470-478. PubMed ID: 34570943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate Cancer Screening in a New Era of Genetics.
    Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
    Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
    Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
    Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake.
    Nilsson MP; Nilsson ED; Silfverberg B; Borg Å; Loman N
    Genet Med; 2019 Jan; 21(1):89-96. PubMed ID: 29875420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
    Tercyak KP; Demarco TA; Mars BD; Peshkin BN
    Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.